HIGHLIGHTS
- who: Jingjing Yang from the (UNIVERSITY) have published the research work: Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology, in the Journal: (JOURNAL) of 19/Oct/2022
- what: In one of the studies performed by Ye et_al Dex was used to modify WS2 nanocomposites to achieve precision with ROS- and thermal-sensitive subcellular organelles, causing irreversible damage to cancer cells. The authors provide a brief perspective on couple ongoing challenges with several potential solutions: incomplete understandings of molecular pathogenesis of tumor heterogeneity lead to noticeable variation in treatment effects in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.